AML blasts, particularly those with IDH1/2 or NPM1 mutations or leukemic stem cell (LSC)-like metabolic profiles, exhibit BCL-2 dependence but maintain oxidative phosphorylation to buffer cellular stress. The gene discussed is BCL2; the disease is acute myeloid leukemia.